These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Nuki G, Bresnihan B, Bear MB, McCabe D, European Group Of Clinical Investigators. Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223 [Abstract] [Full Text] [Related]
25. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, Golder W, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Reddig J, Sieper J. Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476 [Abstract] [Full Text] [Related]
29. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ. N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948 [Abstract] [Full Text] [Related]
30. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V. J Rheumatol; 2004 Aug 28; 31(8):1521-31. PubMed ID: 15290730 [Abstract] [Full Text] [Related]
32. Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept. Haraoui B, Keystone EC, Thorne JC, Pope JE, Chen I, Asare CG, Leff JA. J Rheumatol; 2004 Dec 28; 31(12):2356-9. PubMed ID: 15570634 [Abstract] [Full Text] [Related]
39. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P. Arthritis Rheum; 2007 Dec 28; 56(12):3919-27. PubMed ID: 18050189 [Abstract] [Full Text] [Related]
40. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register. Rheumatology (Oxford); 2006 Dec 28; 45(12):1558-65. PubMed ID: 16705046 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]